[Recent Research Progress and Prospects on Periodontitis Affecting Systemic Comorbidities via the Oral-Gut Axis]. [PDF]
Zhang S, Li Y, Yang Z, Huang H, Pan Y.
europepmc +1 more source
[Modified <i>Chaihu Shugan</i> Powder alleviates cholesterol gallstones in mice with liver depression syndrome by regulating gut microbiota and bile acid metabolism]. [PDF]
Liang R +5 more
europepmc +1 more source
[Dynamic changes in gut microbiota from 1 to 12 months of age in preterm infants]. [PDF]
Song QY, Zhao XL, Ding BL, Lyu Q, Ma LY.
europepmc +1 more source
[Periodontitis and Metabolic Dysfunction-Associated Fatty Liver Disease: From Oral Dysbiosis to Hepatic Metabolic Dysregulation]. [PDF]
Wang M +5 more
europepmc +1 more source
[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease]. [PDF]
Wu ST, Lu XL.
europepmc +1 more source
[Research progress on the correlation between Akkermansia muciniphila and cardiovascular diseases]. [PDF]
Jiang S, Gong L, Zheng H.
europepmc +1 more source
[Research advances on hepatic encephalopathy following transjugular intrahepatic portosystemic shunt]. [PDF]
Ye JJ, Pan YL, Wang J, Lyu Y.
europepmc +1 more source
[<i>Huayu Tongbian</i> Decoction promotes efferocytosis of interstitial Cajal cells in rats with slow transit constipation by inhibiting the PI3K/Akt signaling pathway]. [PDF]
Qiu J +6 more
europepmc +1 more source
[Analysis of the Characteristics of the Oral Virome in Metabolic Dysfunction-Associated Fatty Liver Disease]. [PDF]
Tu Y, Niu C, Huang Z.
europepmc +1 more source
[The microbiota-gut-brain axis in childhood attention-deficit/hyperactivity disorder: mechanisms and therapeutic advances]. [PDF]
Yuan YL, Lan YM, Guo LM.
europepmc +1 more source

